Related Experiment Videos

K-ras mutations and RASSF1A promoter methylation in colorectal cancer

Manon van Engeland1, Guido M J M Roemen, Mirian Brink

  • 1Department of Pathology, University Maastricht, P.O. Box 616 6200 MD Maastricht, The Netherlands.

Oncogene
|May 29, 2002
PubMed

Insights

Ras signaling disruptions in colorectal cancer (CRC) involve K-ras mutations or RASSF1A silencing. K-ras mutations were common, while RASSF1A methylation occurred mainly in K-ras wild-type tumors, suggesting distinct pathways in CRC development.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Human cancers, including colorectal cancer (CRC), exhibit genetic and epigenetic alterations.
  • Ras signaling pathway plays a crucial role in cell growth and is frequently disrupted in various cancers.
  • Aberrant K-ras oncogene activation and epigenetic silencing of tumor suppressor genes like RASSF1A are implicated in cancer development.

Purpose of the Study:

  • To investigate the interplay between K-ras oncogene mutations and RASSF1A promoter hypermethylation in sporadic colorectal cancer (CRC).
  • To determine the frequency of these alterations and their co-occurrence in CRC patient samples.

Main Methods:

  • Analysis of paraffin-embedded tumor tissue samples from 222 sporadic CRC patients.
  • Detection of K-ras codon 12 and 13 activating mutations using molecular techniques.
  • Assessment of RASSF1A promoter hypermethylation via methylation-specific assays.

Main Results:

  • K-ras mutations were found in 39% of CRCs, while RASSF1A methylation was observed in 20%.
  • K-ras mutations alone occurred in 34% of cases, and RASSF1A methylation with wild-type K-ras in 15%.
  • The majority of CRCs with K-ras mutations lacked RASSF1A methylation (P=0.023), indicating these alterations predominantly occur in distinct CRC subsets.

Conclusions:

  • Both K-ras mutations and RASSF1A promoter hypermethylation are significant alterations in sporadic CRC.
  • These genetic and epigenetic events appear to be largely mutually exclusive, suggesting distinct molecular subtypes of CRC.
  • Understanding these distinct pathways can inform targeted therapeutic strategies for colorectal cancer.

Related Concept Videos

The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...